![]() |
市场调查报告书
商品编码
1733384
全球眼科药物和设备市场规模(按产品类型、应用、最终用户、区域范围和预测)Global Ophthalmology Drugs And Devices Market Size By Product Type (Anti-inflammatory, Anti-glaucoma), By Application (Dry Eye, Eye Allergy), By End-User (Hospitals, Medical Clinics), By Geographic Scope And Forecast |
2024 年眼科药物和设备市场规模价值为 570.2 亿美元,预计到 2032 年将达到 881.8 亿美元,2024 年至 2032 年的复合年增长率为 5.60%。
眼部疾病和病症的盛行率不断上升、人们对眼部疾病的健康意识不断增强、强大的分子管道的存在以及眼科药物和设备的日益普及,极大地推动了全球眼科药物和设备市场的成长。本报告对全球眼科药品和设备市场进行了全面的评估。它对关键细分市场、趋势、市场驱动因素、限制因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。
定义全球眼科药物和设备市场
眼科是专注于眼科疾病的诊断和治疗的医学领域。眼科设备用于各种手术,包括白内障手术、青光眼手术和屈光矫正手术。眼科治疗用于治疗多种眼科疾病,包括感染疾病、青光眼和白内障。由于老年族群中黄斑部病变、老花眼和糖尿病视网膜病变等眼部疾病的发生率和盛行率不断上升,全球眼科药品和设备市场正经历显着增长。随着先进的眼科设备的出现,越来越多的人选择透过眼科手术来治疗眼部疾病。
全球眼科药物和设备市场概况
由于老年族群对治疗黄斑部病变、老花眼、糖尿病视网膜病变等各种眼部疾病的微创手术的需求不断增加,预计未来几年全球眼科药物和设备市场将出现显着增长。眼科疾病和障碍的发病率和盛行率不断增加、人们对眼科疾病和障碍的健康意识不断增强、强大的分子管道的存在以及眼科治疗和设备在某些眼部异常和眼部缺陷的治疗和诊断中的应用日益增多,极大地推动了全球眼科治疗和设备市场的增长。
此外,眼科药物和设备领域的技术进步以及对开发新型眼科药物的研发活动的投资增加也在推动市场成长。此外,全球老龄人口的增长、高血糖导致的眼部疾病的增加、医疗保健领域的增长以及政府以资金和津贴形式为诊断设备和治疗程序提供的倡议和支持不断增加,也推动了眼科药物和设备市场的增长。
此外,预计在预测期内,患有眼部疾病的患者数量不断增加、产品开发和发布活动的活性化、对人工水晶体和超音波设备的巨大需求以及新兴国家的增长潜力将为全球眼科药物和设备市场的相关人员提供丰厚的增长机会。然而,治疗程序成本高、多种药物核准延迟、眼科药物认知度低、熟练医务人员短缺以及专利到期预计将在预测期内阻碍全球眼科药物和设备市场的成长。此外,治疗眼科疾病的风险对眼科药品和设备市场的成长构成了挑战。
Ophthalmology Drugs And Devices Market size was valued at USD 57.02 Billion in 2024 and is projected to reach USD 88.18 Billion by 2032, growing at a CAGR of 5.60% from 2024 to 2032.
The increasing prevalence of eye diseases and disorders, rising health awareness among people about the same, presence of a robust pipeline of molecules, and increase in adoption of ophthalmology drugs and devices are driving the growth of the Global Ophthalmology Drugs And Devices Market significantly. The Global Ophthalmology Drugs And Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Ophthalmology Drugs And Devices Market Definition
Ophthalmology is a field of medical science that focuses on the diagnosis and treatment of eye disorders. Ophthalmic devices are used in a variety of procedures such as cataract surgery, glaucoma surgery, and refractive surgery. Ophthalmic drugs are used to treat a wide range of eye diseases, including infection, glaucoma, and cataract. The Global Ophthalmology Drugs And Devices Market is experiencing significant growth because of the rising incidence and prevalence of eye-related disorders such as macular degeneration, presbyopia, and diabetic retinopathy among the geriatric population. With the advent of sophisticated ophthalmic devices, people are increasingly going to opt for ophthalmic surgeries to cure their eye-related disorders.
Global Ophthalmology Drugs And Devices Market Overview
The Global Ophthalmology Drugs And Devices Market is expected to experience remarkable growth in the upcoming years owing to the increasing demand for minimally invasive surgeries in the treatment of various eye-related disorders such as macular degeneration, presbyopia, and diabetic retinopathy among the geriatric population. The increasing incidence and prevalence of eye diseases and disorders, rising health awareness among people about the same, presence of a robust pipeline of molecules, and increase in adoption of ophthalmology drugs and devices in the treatment and diagnosis of certain ocular malformations and eye deficits are fueling the growth of Global Ophthalmology Drugs And Devices Market significantly.
Additionally, technological advancement in the field of Ophthalmology Drugs and Devices and increasing investment in R&D activities for the development of new ophthalmological drugs are also promoting market growth. Furthermore, the rise in the geriatric population across the globe, increasing ophthalmic disorders due to high blood sugar, growth in the healthcare sector, and increasing government initiatives and support in the form of funds and grants for diagnostic equipment and treatment procedures, also boost the growth of the Ophthalmology Drugs And Devices Market.
Moreover, an increase in the patient population of eye-related disorders, increasing product development and launch activities, huge demand for intraocular lenses and phacoemulsification devices, and growth potential in developing nations are expected to provide profitable growth opportunities to the market players in the Global Ophthalmology Drugs And Devices Market during the forecast period. However, high cost associated with the treatment procedures, drug approval delays wherein multiple drugs are in the pipeline, low awareness of ophthalmic drugs, lack of skilled healthcare professionals, and patent expiry is expected to hinder the growth of the Global Ophthalmology Drugs And Devices Market over the forecast period. In addition, risks associated with ocular disease treatment are posing challenges to the growth of the Ophthalmology Drugs And Devices Market.
The Global Ophthalmology Drugs And Devices Market is Segmented on the basis of Product Type, Application, End-User, and Geography.
Based on Product Type, the market is bifurcated into Anti-allergy, Anti-Vascular Endothelial Growth Factor (Anti-VEGF) agents, Anti-inflammatory, Anti-glaucoma, Diagnostic and Monitoring Devices, Surgical Devices, Vision Care, and Others. The anti-inflammatory segment accounts for the highest revenue share of the Global market in 2020 and is expected to dominate the market over the forecast period owing to an increase in the prevalence of allergic conjunctivitis and hypersensitivity reactions, as well as an increase in demand for anti-inflammatory drugs in a wide range of conditions such as uveitis, cystoid macular edema, and scleritis. These factors are driving the growth of this segment.
Based on Application, the market is bifurcated into Dry Eye, Eye Allergy, Glaucoma, Cataract, Eye Infection, Retinal Disorders, Uveitis, and Others. The retinal disorders segment is expected to hold the largest revenue share of the global market during the forecast period owing to the rise in the geriatric population, increase in the prevalence of macular degeneration, and an increase in the sale of ophthalmic drugs for the treatment of retinal disorders. However, the glaucoma segment is expected to grow significantly during the forecast period due to an increase in glaucoma prevalence, a rising need for ophthalmic drugs, and an increase in glaucoma prevention and treatment awareness.
Based on End-User, the market is bifurcated into Hospitals, Medical Clinics, Diagnostic Centers, and Others. The hospitals segment is expected to grow at the highest CAGR during the forecast period owing to the increasing number of patients suffering from various eye-related disorders, and rising awareness about these disorders. Additionally, the availability of various diagnostics and treatment facilities, higher purchasing power, and the presence of highly skilled eye care professionals are driving the growth of the global market in the hospitals segment.
The "Global Ophthalmology Drugs And Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Carl Zeiss AG, Novartis AG, Johnson And Johnson Services, Inc., Allergan, Topcon Corporation, Nidek Co., Ltd., HAAG-STREIT GROUP, Ziemer Ophthalmic Systems, Bausch And Lomb Incorporated, Biotech, VisionCare, Inc., Akorn, Incorporated, Bayer AG, Acucela Inc., Regeneron Pharmaceuticals, Inc, Nicox, Santen Pharmaceutical Co., Ltd. and IRIDEX Corporation, Alcon Inc. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.